Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 5/20 | 0.64 |
| ▸ | SLC6A2 | P23975 | 5/20 | 0.64 |
| ▸ | SLC6A3 | Q01959 | 3/20 | 0.64 |
| ▸ | SLC6A4 | P31645 | 4/20 | 0.62 |
| ▸ | MAOA | P21397 | 2/20 | 0.62 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.62 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.62 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.62 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL81938 | 1.00 | TAAR1 (0.64) | TAAR1SLC6A2SLC6A3SLC6A4MAOA | |
| SCHEMBL22873938 | 1.00 | TAAR1 (0.64) | TAAR1SLC6A2SLC6A3SLC6A4MAOA | |
| Hydrochloric Acid SCHEMBL15204356 | 0.98 | TAAR1 (0.61) | TAAR1SLC6A2SLC6A3SLC6A4MAOA | |
| Hydrochloric Acid SCHEMBL28093667 | 0.95 | TAAR1 (0.59) | TAAR1SLC6A2SLC6A3SLC6A4MAOA | |
| SCHEMBL9467782 | 0.93 | TAAR1 (0.57) | TAAR1SLC6A2SLC6A3SLC6A4MAOA | |
| SCHEMBL10872752 | 0.89 | TAAR1 (0.76) | TAAR1SLC6A2SLC6A3SLC6A4MAOA | |
| SCHEMBL10872755 | 0.89 | TAAR1 (0.76) | TAAR1SLC6A2SLC6A3SLC6A4MAOA | |
| SCHEMBL24017123 | 0.82 | TAAR1 (0.48) | TAAR1SLC6A2SLC6A3SLC6A4CYP2A6 | |
| SCHEMBL22013359 | 0.82 | TAAR1 (0.48) | TAAR1SLC6A2SLC6A3SLC6A4CYP2A6 | |
| SCHEMBL24017125 | 0.82 | TAAR1 (0.48) | TAAR1SLC6A2SLC6A3SLC6A4CYP2A6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 521 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117871845-A | Kit for detecting methyl amphetamine and preparation method thereof | 北京迈康源生物科技有限公司 | 2024-04-12 | — | — | CN | claimed |
| CN-116710084-A | Use of mGluR5 antagonists for the treatment of amphetamine addiction | 诺华股份有限公司 | 2023-09-05 | — | — | CN | claimed |
| CN-116606638-A | Preparation method and application of water-soluble quantum dot | 广纳达康(广州)生物科技有限公司 | 2023-08-18 | — | — | CN | claimed |
| CN-109752536-B | Optical probe based on gold nanoparticle efficient assembly structure and preparation and application thereof | 浙江工业大学 | 2022-03-15 | — | — | CN | claimed |
| CN-111363011-B | Methamphetamine vaccine and preparation method and application thereof | 北京大学 | 2021-08-24 | — | — | CN | claimed |
| CN-111363011-A | Methamphetamine vaccine and preparation method and application thereof | 北京大学 | 2020-07-03 | — | — | CN | claimed |
| CN-105555763-A | Indole-carboxamide derivatives | HOFFMANN LA ROCHE | 2016-05-04 | — | — | CN | claimed |
| CN-105473568-A | 1, 7-naphthyridine derivatives | HOFFMANN LA ROCHE | 2016-04-06 | — | — | CN | claimed |
| CN-105473545-A | Dihydroxyphenyl neurotransmitter compounds, compositions, and methods | AUSPEX PHARMACEUTICALS INC | 2016-04-06 | — | — | CN | claimed |
| CN-105367647-A | Preparation method of methamphetamine artificial antigen | ABON BIOPHARM (HANGZHOU) CO LTD | 2016-03-02 | — | — | CN | claimed |
| EP-2038660-A2 | A METHOD FOR THE PRESUMPTIVE DETECTION OF SUBSTANCES | HERIOT-WATT UNIVERSITY (GB) | 2009-03-25 | — | — | EP | claimed |
| CN-101119963-A | Methamphetamine derivatives and conjugates for use in immunoassays | HOFFMANN LA ROCHE (CH) | 2008-02-06 | — | — | CN | claimed |
| WO-2008001116-A2 | A METHOD FOR THE PRESUMPTIVE DETECTION OF SUBSTANCES | HERIOT-WATT UNIVERSITY (GB) | 2008-01-03 | — | — | WO | claimed |
| CN-101061091-A | Method for purifying benzphetamine hydrochloride | MALLINCKRODT INC (US) | 2007-10-24 | — | — | CN | claimed |
| CN-1313434-C | Darr reaction process of quinone derivative composition to produce free radical and its application | SHANDONG PROVINCIAL RES CT FOR (CN) | 2007-05-02 | — | — | CN | claimed |
| CN-1898201-A | Carbamoyl esters that inhibit cholinesterase and release pharmacologically active agents | SENTION INC (US) | 2007-01-17 | — | — | CN | claimed |
| CN-1526695-A | Darr reaction process of quinone derivative composition to produce free radical and its application | 山东省生物信息工程技术研究中心 | 2004-09-08 | — | — | CN | claimed |
| CN-1124341-C | Monoclonal antibody specific for methamphetamine, hybridoma producing the same, kit containing the same and use thereof | BIOTECHNOLOGY DEV CT (CN) | 2003-10-15 | — | — | CN | claimed |
| EP-0897540-B1 | METHOD FOR DETECTING AND/OR QUANTIFYING A HAPTEN IN A HOMOGENEOUS PHASE AND DEVICE FOR IMPLEMENTATION THEREOF | WALLONE REGION (BE) | 2001-07-04 | — | — | EP | claimed |
| CN-1179469-A | Monoclonal antibody specific for methamphetamine, hybridoma producing the same, kit containing the same and use thereof | BIOTECHNOLOGY DEV CENTER (CN) | 1998-04-22 | — | — | CN | claimed |